54 193
Generic Name: nevirapine
Pill imprint 54 193 has been identified as Viramune 200 mg.
Viramune is used in the treatment of hiv infection and belongs to the drug class NNRTIs. There is no proven risk in humans during pregnancy.
Viramune 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Viramune Images
- Generic Name:
- nevirapine
- Imprint:
-
54 193
- Strength:
- 200 mg
- Color:
- White
- Size:
- 19.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- microcrystalline cellulose
lactose monohydrate
povidone
sodium starch glycolate type A potato
silicon dioxide
magnesium stearate
- Drug Class:
- NNRTIs
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Boehringer Ingelheim Pharmaceuticals, Inc.
- National Drug Code (NDC):
- 00597-0046
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-3844 | Physicians Total Care Inc (repackager) |
| 54569-4561 | A S Medication Solutions LLC (repackager) |
| 55289-0392 | PDRX Pharmaceuticals Inc (repackager) |
| 35356-0071 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
More Viramune resources
- Viramune (Wolters Kluwer)
- Viramune Suspension (Wolters Kluwer)
- Viramune (Cerner Multum)
- Viramune (Micromedex) - Includes Dosage Information
- Viramune (AHFS DI)
- Viramune (FDA)
- Viramune Suspension (FDA)


